Expression of platelet-endothelial cell adhesion molecule-1 in human umbilical vein endothelial cells by exposure to advanced glycosylation end products and inflammatory mediators

Chinese Medical Journal

Volumn 116, Issue 9, 2003, Pages 1336-1340

  Meng, Dan ^a   Liu, Naifeng ^a  

^a SOUTHEAST UNIVERSITY   (China)

Author keywords

Glycosylation end products, advanced; Inflammation mediators; Platelet endothelial cell adhesion molecule 1; Umbilical vein endothelial cells

Indexed keywords

ADVANCED GLYCATION END PRODUCT; BETA ACTIN; BOVINE SERUM ALBUMIN; CD31 ANTIGEN; GAMMA INTERFERON; GLUCOSE; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; ATHEROSCLEROSIS; CELL ADHESION; CELL CULTURE; CELL JUNCTION; CELL MEMBRANE PERMEABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIABETES MELLITUS; ENDOTHELIUM CELL; EXPOSURE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INFLAMMATION; MEDIATOR RELEASE; PATHOGENESIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; STATISTICAL SIGNIFICANCE; UMBILICAL VEIN;

ANTIGENS, CD31; CELLS, CULTURED; ENDOTHELIAL CELLS; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; INTERFERON TYPE II; SERUM ALBUMIN, BOVINE; TUMOR NECROSIS FACTOR-ALPHA; UMBILICAL VEINS;

EID: 0141726699     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Singh R, Barden A, Mori T, et al. Advanced glycation end-products: a review. Diabetologia 2001;44:129-146.
2. 31-deficient mice reveal PECAM-1-dependent and independent functions. J Immunol 1999;162:3022-3030.
3. Tan KC, Chow WS, Ai VH, et al. Advanced glycation end products and endothelial dysfunction in type 2 diabetes. Diabetes Care 2002;25:1055-1059.
4. Brownlee M. Advanced protein glycosylation in diabetes and aging. Annu Rev Med 1995;46:223-234.
5. Busse R, Lamontagne D. Endothelium-derived bradykinin is responsible for the increase in calcium produced by angiotensin-converting enzyme inhibitors in human endothelial cells. Naunyn Schmiedebergs Arch Pharmacol 1991;344: 126-129.
6. 31) cloning and relation to adhesion molecules of the immunoglobulin gene superfamily. Science 1990;247:1219-1222.
7. Varon BD, Jackson DE, Shenkman B, et al. Platelet/endothelial cell adhesion molecule-1 serves as a costimulatory agonist receptor that modulates integrin-dependent adhesion and aggregation of human platelets. Blood 1998;91:500-507.
8. Morigi M, Anigioletti S, Imberti B, et al. Leukocyte-endothelial interaction is augmented by high glucose concentrations and hyperglycemia in a NF-κB-dependent fashion. J Clin Invest 1998;101:1905-1915.
9. Yan J, Liu N. Advanced glycosylation end products increase diacylglycerol levels in cultured human umbilical vein endothelial cells. Chin Med J 2000;113:588-591.
10. Sengoelge G, Fodinger M, Skoupy S, et al. Endothelial cell adhesion molecule and PMNL response to inflammatory stimuli and AGE-modified fibronectin. Kidney Int 1998;54: 1637-1651.
11. Otero K, Martinez F, Beltran A, et al. Albumin-derived advanced glycation end-products trigger the disruption of the vascular endothelial cadherin complex in cultured human and murine endothelial cells. Biochem J 2001;359:567-574.
12. Stewart RJ, Kashxur TS, Marsden PA. Vascular endothelial platelet endothelial adhesion molecule-1 ( PECAM-1 ) expression is decreased by TNF-alpha and IFN-gamma. Evidence for cytokine-induced destabilization of messenger ribonucleic acid transcripts in bovine endothelial cells. J Immunol 1996;156:1221-1228.
13. Rival Y, Del MA, Rabiet MJ, et al. Inhibition of platelet endothelial cell adhesion molecule-1 synthesis and leukocyte transmigration in endothelial cells by the combined action of TNF-alpha and IFN-gamma. J Immunol 1996; 157: 1233-1241.